Department of Translational Medical Sciences, Pediatrics Section, Federico II University of Naples, via S. Pansini 5, 80131, Naples, Italy.
Research Department, Belarusian Research Center for Pediatric Oncology, Hematology and Immunology, Minsk, Belarus.
J Clin Immunol. 2021 May;41(4):756-768. doi: 10.1007/s10875-021-00967-y. Epub 2021 Jan 19.
Human nude SCID is a rare autosomal recessive inborn error of immunity (IEI) characterized by congenital athymia, alopecia, and nail dystrophy. Few cases have been reported to date. However, the recent introduction of newborn screening for IEIs and high-throughput sequencing has led to the identification of novel and atypical cases. Moreover, immunological alterations have been recently described in patients carrying heterozygous mutations. The aim of this paper is to describe the extended phenotype associated with FOXN1 homozygous, compound heterozygous, or heterozygous mutations. We collected clinical and laboratory information of a cohort of 11 homozygous, 2 compound heterozygous, and 5 heterozygous patients with recurrent severe infections. All, except one heterozygous patient, had signs of CID or SCID. Nail dystrophy and alopecia, that represent the hallmarks of the syndrome, were not always present, while almost 50% of the patients developed Omenn syndrome. One patient with hypomorphic compound heterozygous mutations had a late-onset atypical phenotype. A SCID-like phenotype was observed in 4 heterozygous patients coming from the same family. A spectrum of clinical manifestations may be associated with different mutations. The severity of the clinical phenotype likely depends on the amount of residual activity of the gene product, as previously observed for other SCID-related genes. The severity of the manifestations in this heterozygous family may suggest a mechanism of negative dominance of the specific mutation or the presence of additional mutations in noncoding regions.
人源 SCID 是一种罕见的常染色体隐性遗传性免疫缺陷病(IEI),其特征为先天性无胸腺、脱发和指甲发育不良。迄今为止,已有少数病例报道。然而,最近新生儿 IEI 筛查和高通量测序的引入导致了新型和非典型病例的鉴定。此外,最近还描述了携带杂合突变的患者的免疫改变。本文旨在描述与 FOXN1 纯合、复合杂合或杂合突变相关的扩展表型。我们收集了一组 11 例纯合子、2 例复合杂合子和 5 例杂合子反复严重感染患者的临床和实验室信息。除了 1 例杂合子患者外,所有患者均有 CID 或 SCID 的迹象。虽然指甲发育不良和脱发,这些都是该综合征的特征,并非总是存在,但近 50%的患者发展为 Omenn 综合征。1 例携带低功能复合杂合突变的患者表现出迟发性非典型表型。来自同一家庭的 4 例杂合子患者表现出 SCID 样表型。不同突变可能与一系列临床表现相关。临床表现的严重程度可能取决于基因产物的残留活性,正如先前观察到的其他 SCID 相关基因一样。该杂合子家族中表现的严重程度可能提示特定突变的负显性作用机制或非编码区域存在其他突变。